MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS earnings per share and revenue

0A9G earnings per share for the last quarter are -0.01 USD whereas the estimation was -0.01 USD which accounts for 22.22% surprise. Company revenue for the same period amounts to 0.00 USD despite the estimated figure of 36.25 M USD. Estimated earnings per share for the next quarter are -0.01 USD, and revenue is expected to reach 26.88 M USD. Also watch annual changes over time to get a bigger picture of 0A9G earnings per share and revenue dynamics.